Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)

被引：0

作者：

Hijab, A. ^{[1
]}

Tunariu, N. ^{[2
]}

Tovey, H. ^{[3
]}

Alonzi, R. ^{[4
]}

Tree, A. ^{[1
]}

Staffurth, J. ^{[5
]}

Blackledge, M. ^{[6
]}

Padhani, A. R. ^{[7
]}

Stidwill, H. ^{[1
]}

Finch, J. ^{[4
]}

Chatfield, P. ^{[3
]}

Perry, S. ^{[3
]}

Koh, D-M. ^{[2
]}

Hall, E. ^{[3
]}

Parker, C. ^{[1
]}

机构：

[1] Royal Marsden NHS Fdn Trust, Inst Canc Res, Acad Urol Unit, Sutton, Surrey, England

[2] Royal Marsden NHS Fdn Trust, Inst Canc Res, Radiol, Sutton, Surrey, England

[3] Royal Marsden NHS Fdn Trust, Inst Canc Res, Clin Trials Unit, Sutton, Surrey, England

[4] Mt Vernon Canc Ctr, Urooncol, London, England

[5] Velindre Canc Ctr, Radiotherapy, Cardiff, Wales

[6] Royal Marsden NHS Fdn Trust, Inst Canc Res, Radiotherapy & Imaging, Sutton, Surrey, England

[7] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Radiol, Northwood, Middx, England

来源：

关键词：

D O I：

10.1016/j.annonc.2020.08.931

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

672P

引用

页码：S539 / S539

页数：1